Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography

Annals of Neurology

Volumn 29, Issue 4, 1991, Pages 347-355

  Glantz, Michael J ^a   Hoffman, John M ^a   Coleman, R Edward ^a   Friedman, Allan H ^a   Hanson, Michael W ^a   Burger, Peter C ^a   Herndon PhD, James E ^a   Meisler, William J ^a   Schold, S Clifford ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BRAIN TUMOR; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; DIAGNOSIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NUCLEAR MAGNETIC RESONANCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOTHERAPY; TUMOR RECURRENCE;

ADULT; AGED; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DEOXYGLUCOSE; DEXAMETHASONE; EPILEPSY; FLUDEOXYGLUCOSE F 18; FLUORINE RADIOISOTOPES; GLIOMA; HUMAN; MIDDLE AGE; NECROSIS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE PERIOD; RADIATION INJURIES; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0025794065     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410290403     Document Type: Article

References (59)

1. Post‐surgical contrast enhancement mimicking residual brain tumor
2. Postoperative contrast enhancement in patients with brain tumor
3. Contrast enhancement in the postoperative brain
4. Steroidinduced CT changes in patients with recurrent malignant glioma
5. . Effect of dexamethasone treatment on volume and contrast enhancement of intracranial neoplasms
6. CT‐analyses of cerebral tumors under steroid therapy
7. Brain radiation lesions: MR imaging
8. Transient early computed tomographic changes mimicking tumor progression after brain tumor irradiation
9. Delayed necrosis of the brain
10. Failure of computerized tomography to differentiate between radiation necrosis and cerebral tumour
11. Tomographic mapping of human cerebral metabolism: normal unstimulated state
12. Tomographic measurement of local cerebral glucose metabolic rate in human with (F‐18)‐fluoro‐2‐deoxy‐D‐glucose: validation of method
13. Quantitation in positron emission computed tomography: 2. Effects of inaccurate attenuation correction
14. Investigative protocols to treat malignant brain tumors in North America
15. Computed tomography in the postoperative patient
16. Meninges: benign postoperative enhancement on MR images
17. Cranial postoperative site: assessment with contrast‐enhanced MR imaging
18. The effect of steroids on the extravascular distribution of radiographic contrast material and technetium pertechnetate in brain tumors as determined by computed tomography
19. Modification of tumor enhancement and brain edema in computerized tomography by corticosteroids: case report
20. PET, CT, and NMR of cerebral necrosis following radiotherapy of intraarterial chemotherapy for cerebral tumors
21. Te fallacy of the localized supratentorial malignant glioma
22. Surgical management of intracranial gliomas
23. Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme
24. Topographic anatomy and cytologic composition of the untreated glioblastoma multiforme
25. The anatomy of astrocytomas
26. Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen
27. Imaging‐based stereotaxic serial biopsies in untreated intracranial glial neoplasms
28. Stereotactic histologic correlations of computed tomography and magnetic resonance imaging‐defined abnormalities in patients with glial neoplasms
29. Topographic anatomy and CT correlations in the untreated glioblastoma multiforme
30. Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy
31. Reliability of computed tomography in assessing histopathological features of malignant supratentorial gliomas
32. Positron emission tomography with 11C‐methionine and computed tomography of intracranial tumors compared with histopathologic examination of multiple biopsies
33. Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies
34. Intratumoral histologic heterogeneity of gliomas. A quantiative study
35. Diagnostic yield in CT‐guided stereotactic biopsy of gliomas
36. 18F]‐fluorodeoxyglucose and positron emission tomography
37. 18F]fluorodeoxyglucose and positron emission tomography
38. Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomas
39. Positron emission tomography in patients with glioma a predictor of prognosis
40. 18F]fluorodeoxyglucose in brain tumors
41. 18F]fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool
42. Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of reccurence: a PET study
43. Prediction of survival in glioma patients by means of positron emission tomography
44. Changes in cerebral blood flow, oxygen and glucose metabolism following radiochemotherapy of gliomas: a PET study
45. Glucose uptake by gliomas after treatment
46. PET‐FDG of untreated and treated cerebral gliomas
47. Positron emission tomography in the detection of malignant degeneration of low‐grade gliomas
48. Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytoma
49. CT prognostic criteria of survival after malignant glioma surgery
50. Prognostic significance of the pretreatment CT scan on time to progression for patients with malignant gliomas
51. Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low‐grade glioma
52. The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the brain tumor cooperative group
53. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies
54. DSSifferentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography
55. Work in progress: [18F]fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain
56. PET of malignant cerebral tumors after interstitial brachytherapy
57. PET quantitation: blessing and curse